-
The FDA Is Not Ready For Federal Preemption Of Lawsuits Involving Drugs And Medical Devices
Something Old And Something New: Two Items From July 3, 2008 NEJM Show Why Preemption Applied In These Types Of Cases Is Bad Public Policy (Posted by Tom Lamb at DrugInjuryWatch.com) We start with…
-
FDA Needs To Assure Us That There Is Quality Control For Generic Medications Sold In U.S.
In Wake of “Double-Dose” Digitek Pills And ETHEX Morphine Tablets Being Recalled, Drugmaker Ranbaxy Faces Allegations About Fake Data As Regards Quality Of Its Generic Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) A July 15,…
-
Will There Be An Avelox – Liver Toxicity Warning Letter From Bayer Coming Soon In The U.S., Or Not?
In July 2008 FDA Said Avelox, With Other Antibiotics In Fluoroquinolone Class, Would Add A “Black-Box” Warning For Tendinitis And Tendon Ruptures (Posted by Tom Lamb at DrugInjuryWatch.com) On July 8, 2008 the FDA…
-
Sprint Fidelis Litigation Update: 225 Lawsuits Filed In State Courts And Federal MDL As Of June 2008
Medtronic Wants Court To Reject All Injury And Death Cases Based On Riegel Preemption Ruling; Federal MDL Motion To Dismiss Hearing Scheduled For November 2008 (Posted by Tom Lamb at DrugInjuryWatch.com) A July 3,…
-
Permax Update: Two June 2008 Medical Journal Articles Link Permax To Valvular Heart Disease, Again
Reports Of Heart Valve Damage In 2007 Gave Rise To Permax Recalls In U.S. And, Later, In Canada; What About Dostinex, Which Had Similar Reports? (Posted by Tom Lamb at DrugInjuryWatch.com) In January 2007 the…
